nitroglycerin
FDA Approved
Description
Nitroglycerin is a vasodilator used to treat angina pectoris and manage coronary artery conditions. It works by relaxing vascular smooth muscle and dilating coronary arteries to improve blood flow. In rare cases of intramural coronary arterial course, it may provide symptomatic relief of ischemic symptoms.
Indications & Therapeutic Use
angina pectoris, coronary artery disease, myocardial ischemia
Linked Diseases:
Global Availability (6 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
nitroglycerin
| Generic Name | nitroglycerin |
| Brands | 1 brand available |
| Active Ingredient | nitroglycerin |
| Drug Class | angina pectoris |
| Manufacturer | Pfizer |
| Dosage Forms | sublingual tablet 0.3mg, 0.4mg, 0.6mg; transdermal patch; IV infusion |
| Medical Code | C01DA02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 6 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations7 Validated Nodes